Perfluorooctane sulfonate (PFOS) increases metastatic potential of thyroid cancer cells in correlation with activation of multiple invasion-related signaling proteins
Restricted accessResearch articleFirst published online 2026
Perfluorooctane sulfonate (PFOS) increases metastatic potential of thyroid cancer cells in correlation with activation of multiple invasion-related signaling proteins
Perfluorooctane sulfonate (PFOS) is a man-made chemical widely used in many products and acts as an endocrine-disrupting chemical (EDC). PFOS has spread to the environment through industrial manufacturing processes and disposal of PFOS-containing products. There is growing evidence that environmental pollutants may have promoting effects on cancer cell aggressiveness, rapid growth, and metastasis. Thyroid cancer is an endocrine-related cancer that can respond to EDCs. This study aimed to explore the effect of PFOS on the growth and metastatic potential (invasion capability) of FTC-133 human thyroid cancer cells. PFOS exposure for 72 h (1 pM to 10 µM) did not stimulate growth of FTC-133 cells. However, PFOS exposure at low concentration (1 nM) enhanced invasion capability of the cells, with no correlation to the expression level of estrogen receptors. FTC-133 cells exposed to 1 nM PFOS displayed increasing phosphorylation of multiple invasion-related signaling proteins, including Akt, ERK, and EphA2. Our study revealed that PFOS at low concentration may influence thyroid cancer progression by increasing the metastatic potential of cancer cells.
AlloccaCCiraficiAMLaukkanenMO, et al. (2021) Serine 897 phosphorylation of EPHA2 is involved in signaling of oncogenic ERK1/2 drivers in thyroid cancer cells. Thyroid31(1): 76–87. https://doi.org/10.1089/thy.2019.0728
2.
BenninghoffADBissonWHKochDC, et al. (2011) Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro. Toxicological Sciences120(1): 42–58. https://doi.org/10.1093/toxsci/kfq379
CeveniniAOrrùSManciniA, et al. (2018) Molecular signatures of the insulin-like growth factor 1-Mediated epithelial-mesenchymal transition in breast, lung and gastric cancers. International Journal of Molecular Sciences19(8): 2411. Available at: https://doi.org/10.3390/ijms19082411
5.
CousinsITDeWittJCGlügeJ, et al. (2020) The high persistence of PFAS is sufficient for their management as a chemical class. Environmental Science: Processes & Impacts22(12): 2307–2312. https://doi.org/10.1039/d0em00355g
6.
CuiJShiJGaoX, et al. (2024) Associations of exposure to per- and polyfluoroalkyl substances mixture with the numbers of lymph nodes in colorectal cancer patients. Environmental Research240(Pt 1): 117529. https://doi.org/10.1016/j.envres.2023.117529
7.
DillekåsHRogersMSStraumeO (2019) Are 90% of deaths from cancer caused by metastases?Cancer Medicine8(12): 5574–5576. https://doi.org/10.1002/cam4.2474
8.
GogolaJHoffmannMPtakA (2019) Persistent endocrine-disrupting chemicals found in human follicular fluid stimulate the proliferation of granulosa tumor spheroids via GPR30 and IGF1R but not via the classic estrogen receptors. Chemosphere217: 100–110. https://doi.org/10.1016/j.chemosphere.2018.11.018
9.
GuanHGuoZLiangW, et al. (2017) Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways. BMC Cancer17(1): 486. https://doi.org/10.1186/s12885-017-3475-2
10.
HenryNDFairPA (2013) Comparison of in vitro cytotoxicity, estrogenicity and anti-estrogenicity of triclosan, perfluorooctane sulfonate and perfluorooctanoic acid. Journal of Applied Toxicology33(4): 265–272. https://doi.org/10.1002/jat.1736
11.
IshibashiHIshidaHMatsuokaM, et al. (2007) Estrogenic effects of fluorotelomer alcohols for human estrogen receptor isoforms alpha and beta in vitro. Biological and Pharmaceutical Bulletin30(7): 1358–1359. https://doi.org/10.1248/bpb.30.1358
12.
JalaVRRaddeBNHaribabuB, et al. (2012) Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer. BMC Cancer12(1): 624. https://doi.org/10.1186/1471-2407-12-624
13.
KimCSVaskoVVKatoY, et al. (2005) AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma. Endocrinology146(10): 4456–4463. https://doi.org/10.1210/en.2005-0172
14.
KjeldsenLSBonefeld-JørgensenEC (2013) Perfluorinated compounds affect the function of sex hormone receptors. Environmental Science and Pollution Research International20(11): 8031–8044. https://doi.org/10.1007/s11356-013-1753-3
KorentzelosDClarkAMWellsA (2020) A perspective on therapeutic pan-resistance in metastatic cancer. International Journal of Molecular Sciences21(19): 7304. Available at: https://doi.org/10.3390/ijms21197304
17.
LiJCaoHFengH, et al. (2020) Evaluation of the estrogenic/antiestrogenic activities of perfluoroalkyl substances and their interactions with the human estrogen receptor by combining in vitro assays and in silico modeling. Environmental Science & Technology54(22): 14514–14524. https://doi.org/10.1021/acs.est.0c03468
18.
LiFChenLPengB-X, et al. (2024) Perfluorooctane sulfonate promotes the migration of colorectal cancer cells by inducing epithelial-mesenchymal transition. Journal of Environmental Sciences145: 1–12. https://doi.org/10.1016/j.jes.2023.09.031
19.
LiuYLiJDingH, et al. (2022) Perfluorooctane sulfonate (PFOS) triggers migration and invasion of esophageal squamous cell carcinoma cells via regulation of Zeb1. Drug and Chemical Toxicology45(6): 2804–2813. https://doi.org/10.1080/01480545.2021.1991775
20.
LvJLiuCChenF-K, et al. (2021) M2-like tumour-associated macrophage-secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway. Molecular Medicine Reports24(2): 604. https://doi.org/10.3892/mmr.2021.12249
21.
MaestriLNegriSFerrariM, et al. (2006) Determination of perfluorooctanoic acid and perfluorooctanesulfonate in human tissues by liquid chromatography/single quadrupole mass spectrometry. Rapid Communications in Mass Spectrometry20(18): 2728–2734. https://doi.org/10.1002/rcm.2661
22.
MarasMVanparysCMuylleF, et al. (2006) Estrogen-like properties of fluorotelomer alcohols as revealed by MCF-7 breast cancer cell proliferation. Environmental Health Perspectives114(1): 100–105. https://doi.org/10.1289/ehp.8149
23.
MelzerDRiceNDepledgeMH, et al. (2010) Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environmental Health Perspectives118(5): 686–692. https://doi.org/10.1289/ehp.0901584
MoustakasAHeldinC-H (2007) Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression. Cancer Science98(10): 1512–1520. https://doi.org/10.1111/j.1349-7006.2007.00550.x
26.
OchiengJNangamiGNOgunkuaO, et al. (2015) The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis. Carcinogenesis36(Suppl 1): S128–S159. https://doi.org/10.1093/carcin/bgv034
27.
Olsen GearyWBurris JeanMEhresmanDJ, et al. (2007) Half-life of serum elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environmental Health Perspectives115(9): 1298–1305. https://doi.org/10.1289/ehp.10009
28.
O’MalleyYLalGHoweJR, et al. (2012) Invasion in follicular thyroid cancer cell lines is mediated by EphA2 and pAkt. Surgery152(6): 1218–1224. https://doi.org/10.1016/j.surg.2012.08.041
29.
PierozanPKarlssonO (2018) PFOS induces proliferation, cell-cycle progression, and malignant phenotype in human breast epithelial cells. Archives of Toxicology92(2): 705–716. https://doi.org/10.1007/s00204-017-2077-8
30.
SonthithaiPSuriyoTThiantanawatA, et al. (2016) Perfluorinated chemicals, PFOS and PFOA, enhance the estrogenic effects of 17β-estradiol in T47D human breast cancer cells. Journal of Applied Toxicology36(6): 790–801. https://doi.org/10.1002/jat.3210
31.
TaniyasuSKannanKHoriiY, et al. (2003) A survey of perfluorooctane sulfonate and related perfluorinated organic compounds in water, fish, birds, and humans from Japan. Environmental Science & Technology37(12): 2634–2639. https://doi.org/10.1021/es0303440
32.
van GerwenMColicinoEGuanH, et al. (2023) Per- and polyfluoroalkyl substances (PFAS) exposure and thyroid cancer risk. EBioMedicine97: 104831. https://doi.org/10.1016/j.ebiom.2023.104831
33.
van ZijlFKrupitzaGMikulitsW (2011) Initial steps of metastasis: cell invasion and endothelial transmigration. Mutation Research728(1): 23–34. https://doi.org/10.1016/j.mrrev.2011.05.002
34.
VaskoVSajiMHardyE, et al. (2004) Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer. Journal of Medical Genetics41(3): 161–170. https://doi.org/10.1136/jmg.2003.015339
35.
XingJWangGZhaoJ, et al. (2016) Toxicity assessment of perfluorooctane sulfonate using acute and subchronic male C57BL/6J mouse models. Environmental Pollution210: 388–396. https://doi.org/10.1016/j.envpol.2015.12.008
36.
ZhouYSakuraiH (2017) Emerging and diverse functions of the EphA2 noncanonical pathway in cancer progression. Biological and Pharmaceutical Bulletin40(10): 1616–1624. https://doi.org/10.1248/bpb.b17-00446
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
